SHENZHEN, China, Aug. 11, 2017 /PRNewswire/ –To cater to the increasing demand for exclusive health care services among the Chinese high net-worth, Vista, a veteran Continue Reading
PRNews
Ondine’s President and CTO receives 2017 Clinical Research Excellence Award at Global IPA Conference
VANCOUVER, British Columbia, Aug. 11, 2017 /PRNewswire/ — Ondine Biomedical Inc. is pleased to announce that its President and Chief Technology Officer, Dr. Nicolas Loebel, Continue Reading
Korea Institute of Science and Technology (KIST) Develops a New Drug for Alzheimer’s Disease
— Development of a new, innovative drug for Alzheimer’s disease overcoming the limits of existing medicines. — Offering a new hope of developing a global Continue Reading
Tokyo Institute of Technology and Kawasaki City are Combining Forces in R&D on Computational Drug Discovery for Middle Molecules at Kawasaki KING SKYFRONT
TOKYO, Aug. 4, 2017 /PRNewswire/ — On July 31, Tokyo Institute of Technology (Tokyo Tech) and Kawasaki City announced that they are combining forces to Continue Reading
European Patent Office to Grant Merck’s Patent Application for CRISPR Technology
– Patent application covers integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR – Related patent application recently awarded in Continue Reading
Frost & Sullivan Acclaims Shimadzu for Delivering a Product Line of Versatile and Innovative Radiography Solutions
Shimadzu’s products utilize advanced robotic capabilities and next-generation digital imaging technologies LONDON, Aug. 3, 2017 /PRNewswire/ — Based on its recent analysis of the general radiography Continue Reading
A Delegation led by Director Li Weimin of West China Hospital, Sichuan University Visited the UK
CHENGDU, China, Aug. 2, 2017 /PRNewswire/ — On July 9-14 this year, a delegation led by director Li Weimin of West China Hospital, Sichuan University Continue Reading
Frost & Sullivan Lauds CytoSorbents for Leading the Critical Care Immunotherapy Segment with its Novel Blood Purification Solution, CytoSorb®
By controlling dangerous inflammation, CytoSorb® is enabling superior outcomes in critically-ill patients, with reduced overall costs of intensive care in its sights LONDON, Aug. 2, Continue Reading
Frost & Sullivan Commends Credence ID’s Rollout of CredenceTAB(TM), a Biometric Tool that Combines Document Reading and Biometric Enrollment and Verification in a Portable Device
Credence ID’s unique product suite offers convenience, portability, and customization to satisfy a wide range of identification projects SANTA CLARA, California, Aug. 1, 2017 /PRNewswire/ Continue Reading
Verdezyne Groundbreaking Ceremony in Malaysia Commemorates Initiation Of The World’s First Biobased DDDA Plant
-VerdePalm Plant to Use Sustainable Palm-based Materials to Manufacture Components of FerroShield™ Dibasic Acid Mixture for Superior Corrosion Inhibition CARLSBAD, Calif. and KUALA LUMPUR, Malaysia, July Continue Reading